Christopher Williams Email & Phone Number

Norwalk, Connecticut, Us

• Direct all facets of business relationships with pharma, biotech, and technology partners to create continuing opportunities.• Cultivate and maintain relationships with cross-functional partners, negotiate various contracts and deals.• Oversee the technology development of an online patient-facing registry.• Secured and completed multiple technology contracts in areas such as NGS, EMR/EHR extraction, AI analysis, mobile phlebotomy, and multiple outside consultants.• Chair and administer various grant programs for both academic medical centers and technology partners. • Maintain responsibility for managing ongoing relationships with top pharma and biotech partners in all areas, including research, patient education, and events.• Close new business and develop negotiating strategies by coordinating goals and requirements with company objectives and procedures.• Remain accountable for the coordinated management of multiple related projects directed toward strategic business and other organizational objectives.• Build credibility, establish rapport, and maintain communication with academic, corporate and governmental clients at the highest levels.

• Spearheaded various business development efforts, including product support, market analysis, product menu expansion, and strategic partnerships.• Collaborated with Sales to identify and gain an audience with leading labs for product introduction.• Completed CE-IVD mark and registration of products in the EU and Turkey.• Appraised and reviewed new and existing technologies for competitive analysis purposes.• Remained abreast of the current disease markets, identified new biomarkers for potential product opportunities.• Initiated and closed agreements for various business segments.• Fostered and developed new business and strategic partnerships in the clinical diagnostics market.• Served as a key contributor in the strategic planning and execution of sales and marketing activities.• Engaged and encouraged emerging leaders, developing a goal-oriented mindset with accountability to personal and professional development.

Rotterdam, Zuid-Holland, Nl

• Headed US commercialization strategy for the Oncology Product portfolio.• Identify and initiate CLIA laboratory implementation of products and services.• Captured key research/clinical partnerships with leading academic/pharmaceutical laboratories.• Devised and developed a comprehensive billing and reimbursement strategy for the US market.• Establish scientific advisory board/KOL relationships/speaker board.• Established world class SAB in Multiple Myeloma space• Established network of KOLs as advocates for products• Guided and supervised the redesign of various marketing materials, including website content, print materials, and social media marketing.• Conducted competitive analysis for partnership acquisition. • Represented the company at key scientific conferences symposium and attended partnering meetings.

Shelton, Ct, Us

• Drove business development by establishing Oncology Market Strategy within the Diagnostics Division.• Established operating plan goals for cancer diagnostics products, ranging from $500K – 1M.• Launched hematological malignancy focused microarray platform (20+ new customers).• Coordinated and executed various activities that included KOL interviews, reimbursement strategy, go to market readiness with cross-functional teams (clinical validation, marketing/sales, senior management), and sales force training.• Collaborated with KOLs regarding product advocacy and education efforts. • Presented product specific talks at meetings and NCI Cancer Centers (Grand Rounds/Tumor Boards).• Dictated product placement at trade shows, educational seminars, and print/web media.• Formed and developed a clinical dossier and relationships with internal and external stakeholders for reimbursement.• Orchestrated, coordinated, and oversaw clinical validity and clinical trial programs at three well-known cancer centers. • Contributed to the Next Generation Sequencing diagnostics portfolio by working with PerkinElmer’s CLIA certified NGS lab to plan entry into diagnostic sequencing.• Leveraged KOL relationships for NGS sales opportunities and established NGS platform vendor relationships.• Represented PerkinElmer on the Molecular Pathology Coding and Next Generation Sequencing Workgroup.

Shelton, Ct, Us

• Tasked with technical/sales support for Molecular Diagnostics products.• Assisted and supported customers and the sales organization in the area of Array Comparative Genomic Hybridization (CGH).• Authored and published three application notes in 2008 (Applications: Stem Cells, Oncology, and Developmental Delay).• Provided extensive customer support that included training, technical seminars, and troubleshooting (20+ seminars/year).

Shelton, Ct, Us

• Charged with applications support for Functional Genomic/Proteomic products.• Published applications notes for piezoelectric printing and fluorescent scanners. • Played a key role in R&D for product improvements on aCGH products.• Incorporated the voice of customer interviews to define R&D product pipeline for array CGH products.• Supervised assay development in the area of protein/peptide microarrays.• Optimized conditions for piezoelectric deposition of antibodies on glass slides.• Developed sandwich type assays for the quantitative monitoring of key signal transduction proteins.• Responsible for SBIR phase I grant data and report submission as well as phase II proposal.

Us

Responsible for assay development in the area of protein/peptide microarrays• Optimized conditions for piezoelectric deposition of antibodies on glass slides• Developed sandwich type assays for the quantitative monitoring of key signal transduction proteins• Responsible for SBIR phase I grant data and report submission as well as phase II proposal

Cambridge, Ma, Us

Responsible for development and implementation of new technologies in the area of protein/protein interactions and proteomics, with an emphasis on biosensors• Developed novel interface for the analysis of proteins bound to biosensor surfaces by mass spectrometry• Developed novel assay for GPCR “de-orphaning” using biosensor surfaces and mass spectrometry. Allowed for the discovery of possible novel GPCR ligands in less than two months• Developed assays that predicted the plasma binding properties of small molecules in a high throughput mode. Increased the number of drugs screened from 5-10 a week to 100 per day• Prepared numerous intramural and extramural project proposals and gained corporate approval • Participated in the assessment of the current and future needs for new technologies in the molecular validation of targets. Assisted in the design and implementation of ‘proof-of-concept’ studies• Supervised and advised personnel as both direct and indirect reports on team and core technology groups• Project leader for international co-development project for an array biosensor

Basel, Basel-Stadt, Ch

• Designed and validated high throughput assays for drug discovery in oncology.• Developed assay platforms for target validation and screening of small molecules for oncology candidates (PCR, Cloning & Expression, IP & Western Blots).• Introduced surface plasmon resonance biosensors as a tool for target validation and assay development Implemented Biacore® for use in mutation analysis of BCR/Abl binding peptides as well as kinetic analysis of lead oncology targets binding to phosphotyrosine containing peptides. • Assessed the current and future needs for new technologies in the molecular validation of targets and oversaw the design and implementation of the ‘proof-of-concept’ studies.

Kenilworth, New Jersey, Us

• Functioned as a contributing member of the teams responsible for various research projects for drug development in tumor biology.• Responsible for protein expression and purification for the RAS p21 project. Expressed in E. coli, baculovius, and mammalian cell lines.• Set up in vitro and in vivo secondary assays to screen and validate lead compounds for ant-tumor activity.• Small animal handling and surgery (mice, rats, and rabbits) for drug studies and antibody production.

Master Of Science - Ms, Biochemistry

Bachelor Of Science - Bs, Microbiology/Molecular Biology